$NXHZ sterling with his unreal due diligence and way with
$NXHZ sterling with his unreal due diligence and way with words once again ... just when I didn't think I could get more bullish on this little gem ... loading ...
Quote:
Koldkash, with your NXHZ Valuation…
The .15 Earnings Per Share (EPS) for NXHZ that you mentioned for being derived as the latest EPS for NXHZ sounds like a fair assessment. If they secure the acquisition from shares already existing as like how the CEO already mentioned, then this means that a .15 EPS is derived on the presumption that the OS was maxed out to its Authorized Shares (AS) amount of 250 Million shares as a worst case scenario (although confident that it won’t happen here) and also presuming that out of the $100 Million in ”uranium” reserves, only 37.5% will be immediately captured resulting in $37,500,000 for a Net Income amount to get the .15 EPS that you mentioned as indicated below...
$37,500,000 ÷ 250,000,000 (Maxed OS) = .15 EPS
If they partner with a major company as like has been mentioned, then I would give the life of the Gold Eagle Mine a 5 year life span to capture the reserves. This means that I would take that .15 EPS and divide it by 5 years to equate to basically an EPS of .03 per share.
Here’s where it can get a little tricky because now to derive the fundamental share price of where NXHZ should trade from the closure of this huge ”uranium” deal, we must multiply the EPS by a Price to Earnings (P/E) Ratio. There are a few different ways to logically derive what P/E Ratio to use, but I like to use what’s ”officially” indicated within the Yahoo Finance database for the ”Industry” of which a stock would trade. NXHZ has a $100 Million deal for ”uranium” confirmed by the Department of Energy (DOE) as indicated within the link below:
www.nexhorizoninfo.com/#
The P/E Ratio is the growth rate for stocks/companies within a sector or industry that are generating revenues/Income/profits. These companies are used as the standard for other companies to be measured upon to determine the rate of its growth. With the indicated P/E Ratio below from Yahoo Finance… it is what it is. It is not speculative or something that I made up. It is confirmed from an official database of registered stocks that trades within that Industry/Sector. I think it is important to read the link/post below to understand the different concepts for interpreting a P/E Ratio before reading any further:
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...
Continue Reading
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...
Continue Reading
Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...
Continue Reading
A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...
Continue Reading
Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...
Continue Reading
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...
Continue Reading
Top 5 Most Recently Viewed Articles
DriveCentric Partners with Dealer Pay for Seamless Payment Integration DriveCentric is making waves in the automotive industry with its recent partnership with Dealer Pay. This collaboration aims to revolutionize how dealerships handle customer payments within their CRM systems. By integrating Dealer Pay's payment solutions into DriveCentric's platform, dealerships can...
Continue Reading
Concerns Surrounding Coty Inc. Pomerantz Law Firm is currently looking into claims related to Coty Inc. (NYSE: COTY), a significant player in the beauty industry. Investors who have stakes in Coty are encouraged to understand the implications of these developments and how they might affect their investments. Danielle Peyton at the Pomerantz Firm is available for inquiries...
Continue Reading
Transformative AI Tools for Leaders In today's fast-paced business world, leveraging advanced technology can greatly influence decision-making. Rossman Partners has launched a robust AI-driven advisory tool called Big Bet Leadership GPT. This cutting-edge solution is tailored to assist executives and entrepreneurs in navigating high-pressure scenarios, boosting their...
Continue Reading
Tesla's Remarkable Stock Performance Tesla Inc. (NASDAQ: TSLA) has proven time and again to be a formidable player, not only in the electric vehicle (EV) sector but also in the stock market. The company's stock has shown impressive gains, rising approximately 55.82% within a brief period. Over the past year, TSLA has seen significant growth of 45.02%, and year-to-date, it...
Continue Reading
Metagenomi's Class Action Lawsuit Overview Investors of Metagenomi Inc. (NASDAQ: MGX) need to be aware of a class action lawsuit that has been initiated, seeking accountability after critical revelations about the company's operations. This legal action revolves around securities purchased in the defined class period, putting pressure on the company's management to...
Continue Reading